TNFSF10 and breast cancer: Despite that the specific role of MSCs in the tumor microenvironment is not fully understood, different studies reported that TRAIL expressed by MSCs can overcome resistance in colorectal and breast cancer to treatment with recombinant TRAIL (44, 45).